Ghent University Academic Bibliography

Your filters: cql: author="Lindner, Sven" or (type any "bookEditor issueEditor" and editor="Lindner, Sven")

Add to list
- Journal Article
- A2
- open access
The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease

Bram De Wilde (UGent) , Anneleen Beckers (UGent) , Sven Lindner, Kristina Althoff, Katleen De Preter (UGent) , Pauline Depuydt, Pieter Mestdagh (UGent) , Tom Sante (UGent) , Steve Lefever (UGent) , Falk Hertwig, et al.

(2018) ONCOTARGET. 9(9). p.8334-8349
Add to list
- Conference Paper
- C3
- open access
Long non-coding RNAs as novel components in the TP53 pathway

Dries Rombaut, Steve Lefever (UGent) , Jan Koster, Sven Lindner, Johannes Schulte, Rogier Versteeg, Peter van Sluis, Jo Vandesompele (UGent) and Pieter Mestdagh (UGent)

(2016) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
Targeting MYCN-driven transcription by BET-bromodomain inhibition

Anton G Henssen, Kristina Althoff, Andrea Odersky, Anneleen Beckers (UGent) , Richard Koche, Franki Speleman (UGent) , Simon Schaefer, Emma Bell, Maike Nortmeyer, Frank Westermann, et al.

(2016) CLINICAL CANCER RESEARCH. 22(10). p.2470-2481
Add to list
- Conference Paper
- C3
lncRNAs as upstream regulators and downstream effectors of TP53 in neuroblastoma

Dries Rombaut, Steve Lefever (UGent) , Pieter-Jan Volders (UGent) , Jan Koster, Sven Lindner, Johannes Schulte, Alan Van Goethem (UGent) , Rogier Versteeg, Peter van Sluis, Jo Vandesompele (UGent) , et al.

(2015) Keystone symposia on Molecular and Cellular Biology, Abstracts.
Add to list
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin

Kristina Althoff, Sven Lindner, Andrea Odersky, Pieter Mestdagh (UGent) , Anneleen Beckers (UGent) , Sarah Karczewski, Jan J Molenaar, Anna Bohrer, Shirley Knauer, Franki Speleman (UGent) , et al.

(2015) INTERNATIONAL JOURNAL OF CANCER. 136(6). p.1308-1320
Add to list
- Journal Article
- A1
- open access
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies

Kristina Althoff, Anneleen Beckers (UGent) , Emma Bell, Maike Nortmeyer, Theresa Thor, Annika Sprüssel, Sven Lindner, Katleen De Preter (UGent) , Alexandra Florin, Lukas C Heukamp, et al.

(2015) ONCOGENE. 34(26). p.3357-3368
Add to list
- Conference Paper
- C3
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Irina Lambertz (UGent) , Candy Kumps (UGent) , Shana Claeys (UGent) , Sven Lindner, Anneleen Beckers (UGent) , Els Janssens (UGent) , Daniel Carter, Alex Cazes, Belamy Cheung, Marilena De Mariano (UGent) , et al.

(2015) New trends in anticancer drug development, CNIO Frontiers Meeting, Abstracts.
Add to list
- Conference Paper
- C3
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Irina Lambertz (UGent) , Candy Kumps (UGent) , Shana Claeys (UGent) , Sven Lindner, Anneleen Beckers (UGent) , Els Janssens (UGent) , Daniel Carter, Alex Cazes, Belamy Cheung, Marilena De Mariano (UGent) , et al.

(2015) Belgian Society of Human Genetics, 15th Annual meeting, Abstracts.
Add to list
- Conference Paper
- C3
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Irina Lambertz (UGent) , Candy Kumps (UGent) , Shana Claeys (UGent) , Sven Lindner, Anneleen Beckers (UGent) , Els Janssens (UGent) , Daniel Carter, Alex Cazes, Belamy Cheung, Marilena De Mariano (UGent) , et al.

(2015) OncoPoint, 3rd Meeting, Abstracts.
Add to list
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Irina Lambertz (UGent) , Candy Kumps (UGent) , Shana Claeys (UGent) , Sven Lindner, Anneleen Beckers (UGent) , Els Janssens, Daniel R Carter, Alex Cazes, Belamy B Cheung, Marilena De Mariano, et al.

(2015) CLINICAL CANCER RESEARCH. 21(14). p.3327-3339

Academic Bibliography

The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease

Long non-coding RNAs as novel components in the TP53 pathway

Targeting MYCN-driven transcription by BET-bromodomain inhibition

lncRNAs as upstream regulators and downstream effectors of TP53 in neuroblastoma

miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies

Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Contents

Support

Contact